Clinical Trial Update: Erenumab For Treatment of Hemicrania Continua [Phase 2]

View source ↗

Summary

Phase 2 trial of erenumab for hemicrania continua was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemicrania Continua

Drugs mentioned

• erenumab (erenumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Hemicrania Continua | Phase 2 | Status: TERMINATED | Results posted: 2023-02-17